Trial Profile
Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola) in the Late Follicular Phase, a Randomised Controlled Pilot Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jul 2023
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary) ; Ganirelix; Triptorelin
- Indications Female infertility
- Focus Therapeutic Use
- 26 Apr 2023 Status changed from recruiting to completed.
- 24 Mar 2020 Planned End Date changed from 1 Jun 2019 to 1 Aug 2020.
- 24 Mar 2020 Planned primary completion date changed from 1 Jun 2019 to 1 Aug 2020.